Anatomic Pathology Market Size & Share 2024 – 2032

Anatomic Pathology Market Size

The global anatomic pathology market size was valued at around USD 36.7 billion in 2023 and is estimated to grow at 7.8% CAGR from 2024 to 2032. Anatomic pathology is a pathological subdivision that seeks to diagnose a disease through the investigation of tissues and organs in surgical specimens. It comprises the examination of changes in the structure and functions of tissues and organs that are caused by the disease. Anatomic pathologists employ histopathology, cytopathology, or autopsy pathology, among others, when synechiae in specimens are analyzed.

The market growth of anatomic pathology is propelled primarily by increasing incidences of cancer and other target disorders across the world. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. As a result of the increasing disease burden across the globe, there is an increasing demand for advanced diagnostic techniques such as histopathology and cytopathology, which are vital and integral in disease management.

Apart from that, an increase in the adoption of biomarkers, a rise in cancer drug clinical trials, and improvements in equipment are some of the factors that are fueling the anatomical pathology market. Biomarkers increase the accuracy of diagnosis, while clinical trials demonstrate the importance of accurate evaluation of tissues by histopathology. Furthermore, the introduction of new technology such as digital pathology also improves the speed and accuracy of diagnoses, hence supporting the anatomical pathology market growth.
 

Anatomic Pathology Market Trends

The field of anatomic pathology has witnessed significant technological advancements that have transformed the way diseases are diagnosed and managed. These technological refinements help to significantly decrease the time taken to make a diagnosis while streamlining the pathology laboratory processes.
 

• A notable trend in the market is the increasing acceptance of digital pathology solutions. Digital pathology is a concept that provides digital means to acquire, store and interpret pathology information using high-resolution digital images scanned from glass slides. This is a major improvement on traditional microscopy whereby they can access the equipment regardless of their geographical location allowing for more effective and timely communication and consultation. The case organization and case retrieval systems which employ software tools for collecting and recognizing patterns and abnormalities also enhance efficiencies greatly.
   
• As a result of these advancements in technology, the incorporation of genomics, proteomics, and metabolomics within anatomical pathology has improved the comprehension of disease on cellular and molecular levels. The integration of histopathology and molecular testing via advanced technology has enabled one to practice personalized medicine whereby treatment regimens are made based on specific biomarkers and genetic predispositions of a person.
   
• As to new technologies that have emerged, high-throughput screening makes it possible to test several samples at once which has led to a much shorter time required for diagnosing diseases. This is very relevant in clinical research and clinical testing of new treatment options and affects different types of diseases quite effectively and quickly, allowing for prompt assessments of the new treatment options.
   
• When it comes to AI technologies, they have also penetrated anatomic pathology in the form of machine learning which increases accuracy in diagnostic. These tools offer large data analysis and recognition of slight histopathologic characteristics that the eye wouldn’t be able to see, which is extremely useful in complicated types of cancer. Also, machine learning models help to predict the future based on the past and this information can help pathologists decide on how to treat the patient/based on data and outcomes for treatment of similar patients in the past.
   
• The above-mentioned factors in combination boost the market growth for anatomic pathology instruments.
   

Anatomic Pathology Market Analysis

Based on product and service, the market is segmented into instruments, consumables, and services. The instruments segment is bifurcated into microtomes, cell processors, tissue processing systems, slide staining systems, embedding systems, coverslippers, and other instruments. Further, the consumables segment is segmented into antibodies, kits and reagents, probes, and other consumables. The services segment is further bifurcated into histopathology and cytopathology. The consumables segment dominated the market with the largest revenue of USD 19.2 billion in 2023 and is expected to grow at a significant CAGR over the forecast period.
 

• Diagnostic accuracy in anatomic pathology can also be improved with the use of high-quality consumables such as precision-cut slides and reliable reagents. These materials ensure that tissue samples prepared for the pathologist are properly stained in such a way that the cellular structures and abnormalities present in the sample are clearly seen and easily analyzed.
   
• Moreover, also the standardized consumables, which do not differ between different pathology laboratories, make it possible to get reliable diagnostic outcomes, which is paramount for diagnosis preparatory processes. Precut clothes, ready-to-use slide staining reagents, and pre-calibrated controls reduce human error in sample preparation, resulting in uniformity that aids pathologists in achieving set objectives.
   
• Ready-to-use consumables supplement the already improved work processes in the pathology laboratories. Ready-to-use and validated kits cut down on the time that would otherwise be used in laborious preparation, which would have required the laboratory workforce to prepare, enabling them to spend more time on sample analysis. This time and resource optimization improves productivity.
   
• Regardless, the top-mentioned aspects are further driving the market growth.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the anatomic pathology market is segmented into disease diagnostics and research. Within the disease diagnostics segment, the market is further divided into cancer and other diseases. The cancer segment is sub-divided into breast cancer, gastrointestinal cancer, lung cancer, prostate cancer, and other cancer types. The diseases diagnostics segment of the market, which held a 78.4% share in 2023, is poised for substantial growth in the coming years.
 

• Anatomic pathology, in conjunction with review, allows tissue and cell structures. This aids in the study and understanding of the morphology of disease processes, and often the pathologists can determine the type, stage, and grade of cancer just from the scan analysis as it helps in confirming the diagnosis that was made during the tumor biopsies. Tumor biopsies usually contain useful information such as tissue structure presenting malignancy and tumor treatment.
   
• Currently, the combination of molecular testing such as genomics and proteomics with anatomic pathology has broadened the field of personalized medicine, such as establishing even a greater degree of confidence. Instead of using chemotherapy, simply targeting specific genes may sense some improvement.
   
• In addition, certain methods of examination like histological techniques in addition to cytological methods in the field of anatomic pathology have been effective in the diagnosis of some diseases in their very initial stages even before the clinical picture is noticed by the patient. It is also possible to establish a diagnosis of cancer or precancerous states by looking at early cellular changes in biopsies or surgical resection specimens. Such detection in patients ameliorates the situation by allowing active efforts at that stage of the disease.
   

Based on end use, the anatomic pathology market is segmented into hospitals, diagnostic centers, and other end users. The hospitals segment of the market, which held a 55.4% share in 2023, is poised for substantial growth in the coming years.
 

• It is essential that hospitals provide access to a variety of controls and ancillary diagnostic tools vital to anatomic pathology, such as radiology and molecular diagnostics, as these provide comprehensive patient coverage. This holistic approach of multiple diagnostic capabilities provides timely assistance when dealing with the intricacy of a condition, thus ensuring better patient outcomes.
   
• Moreover, modernization in molecular testing connected with anatomic pathology boosts the ability of a hospital to practice personalized medicine. The fusion of pathology with genetics and biomarker testing enables effective management of cancer therapy in individual patients. This patient-oriented approach improves not only the effectiveness of therapy but also the satisfaction of the patient as the treatment is exclusively based on his status.
   
• In addition, anatomic pathology contributes significantly to the wellness of patients through effective surgical intervention in the hospitals. Pathologists perform tissue samplings during surgeries and provide instant details on the margins of the tumor and the disease. This aids in avoiding unnecessary procedures for the surgeons, thus increasing the chances of achieving successful surgical procedures.

The U.S. dominated the North American anatomic pathology market with the largest revenue of USD 13.6 billion in 2023.
 

• Numerous studies show that the American market has a high rate of cancer, and according to the report by Centers for Disease Control and Prevention (CDC), 1,603,844 newly diagnosed cases and 602,347 deaths were registered in 2020. This clearly points to the importance of anatomic pathology in the comprehensive diagnosis of cancer and in developing the most suitable treatment plans for the patients, thereby providing a more helpful understanding of the various aspects of the tumor.
   
• In addition, the U.S. has an advanced healthcare system with well-developed medical centers and pathology clinics. The presence of advanced infrastructure encourages the introduction of modern solutions in the field of anatomic pathology assistance, such as digital pathology, molecular diagnostic approaches, and AI assistance tools, improving the patient care experience.
   
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment over the forecast period.
   

The anatomic pathology market in the UK is expected to experience significant and promising growth from 2024 to 2032.
 

• The NHS has greatly enhanced the pathology services within the UK. Due to universal coverage of health care, the NHS endorses the availability of pathology services to a vast population through advanced anatomic services.
   
• The UK government has prioritized the improvement and development of technology tools such as digital pathology and molecular diagnostics by providing a considerable amount of funding. Moreover, The investments from the government and pharmaceutical industry into biomedical research fuel advancements in anatomic pathology tools in the UK. The advancements make the world seek to achieve higher diagnostic ratios and better treatments.
   

Japan's anatomic pathology market is anticipated to witness lucrative growth between 2024 and 2032.
 

• Japan is experiencing one of the largest increases in the elderly population, which is contributing to the slow growth in aging-related chronic diseases like cancer. Consequently, this population shift increases the demand for anatomic pathology services, as the management of age-associated diseases necessitates precise diagnostics.
   
• There exists a set of rules and guidelines regarding medical diagnostic services, and Japan is one of the few countries that have issued them, especially with regards to anatomic pathology. Agencies such as PMDA provide for the verification of diagnostic devices and thus enhance the confidence of the consumers in the pathology services.
   

The anatomic pathology market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• The Saudi government, within the context of Vision 2030, has executed several comprehensive actions with regards to the healthcare system. Several advanced laboratories and medical care centers were built, which help in improving the market for anatomic pathology services in the country.
   
• There have been active efforts in Saudi Arabia on addressing public health concerning chronic diseases and encouraging early diagnosis of diseases. Such programs motivate the population to go for regular screenings and evaluations. As a result, there is an increase in anatomic pathology services.
   

Anatomic Pathology Market Share

The market is fiercely competitive, consisting of a variety of international players alongside small to medium-sized companies vying for market share. One of the crucial components of the overall marketing strategy is the continuous improvement of the technologies and methods of diagnosis such as digital pathology and advanced molecular diagnostics. There is a great deal of concentration among the industry leaders, who frequently seek to influence the market by making daring expenditures in the appropriate research and development. Also, mergers, acquisitions, and strategic partnerships are effective in enhancing market competencies and global footprints owing to the dynamic changes in healthcare needs and the business environment. As the trend towards precision medicine and personalized diagnostics as well as sophisticated laboratory services develops, so do the competitive factors, with implications for service provision and the perception of anatomic pathology services by healthcare providers and patients.
 

Anatomic Pathology Market Companies

Some of the eminent market participants operating in the anatomic pathology industry include:

• Supply-side
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Cardinal Health
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • Merck
  • Thermo Fisher Scientific 
• Demand-side (Laboratories)
  • Ampath Laboratories
  • Al Borg Medical Laboratories
  • Biolab
  • Eurofins Scientific
  • Laboratoires Réunis
  • Lifebrain Group
  • Lancet Laboratories
  • Medsol Diagnostics
  • Synlab Group
  • Unilabs
     
• Comprehensive range of advanced instrumentation for pathology workflows.
   
• High-precision diagnostic tools for molecular and tissue analysis.
   
• Integrated solutions enhancing laboratory automation and efficiency.
   
• Scalable solutions for both small and large laboratories.
   

Anatomic Pathology Industry News:

• In April 2023, Agilent Technologies partnered with PathAI to provide biopharmaceutical organizations with a solution that combines Agilent's assay development expertise and PathAI's advanced algorithm platform. By integrating Agilent's anatomic pathology workflow and staining systems with PathAI's AISight digital pathology software, this partnership aims to deliver AI-driven assays from research to clinical application.
   
• In June 2022, Roche announced the launch of the BenchMark ULTRA PLUS system, its newest advanced tissue staining platform. The system enabled quick and accurate test results, allowing clinicians to make timely decisions regarding a patient's care journey. This launch benefited the company by enhancing its product portfolio, strengthening its position in the diagnostics market, and improving customer satisfaction through increased efficiency in clinical decision-making.
   

The anatomic pathology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product and Service

• Instruments
  • Microtomes
  • Cell processors
  • Tissue processing systems
  • Slide staining systems
  • Embedding systems
  • Coverslippers
  • Other instruments 
• Consumables
  • Antibodies
    • Primary antibodies
    • Secondary antibodies
  • Kits and reagents
    • Stains and solvents
    • Fixatives
    • Other kits and reagents
  • Probes
  • Other consumables
• Services
  • Histopathology
  • Cytopathology

Market, By Application

• Diseases diagnostics
  • Cancer
    • Breast cancer
    • Gastrointestinal cancer
    • Lung cancer
    • Prostate cancer
    • Other cancer types
  • Other diseases 
• Research

Market, By End Use

• Hospitals
• Diagnostic centers
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE